No profile data available.
Kestra Medical Technologies, Ltd. (KMTS) is a healthcare company in the heart treatment equipment industry, based in Kirkland, United States, with about 443 full-time employees.
It reported revenue of $95.13 million for fiscal year 2026, up 59.0% from fiscal year 2025, and net income of -$131.61 million. In Q1 2027 (the quarter ended July 31, 2026) revenue was $30.97 million, up 59.9% from a year before. Its market capitalization was $1.61 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended April 30, 2026; market data as of October 9, 2026.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights.
Kestra Medical Technologies reported $95.13 million in revenue for fiscal year 2026, up 59.0% from $59.82 million in fiscal year 2025. In Q1 2027 revenue was $30.97 million.
$1.61 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Pulse Biosciences, Inc. (PLSE), iRhythm Technologies, Inc. (IRTC), AtriCure, Inc. (ATRC), Anteris Technologies Global Corp. (AVR).